Report generated from BNF with QVH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 09 10 2015

TA Title Formulary Status Section TA Link Annotation Number

ABCIXIMAB Non Formulary 2.9 Antiplatelet

2.5 Hypertension and ->2.5.5 Drugs Accupro® Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->QUINAPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Accuretic® Non Formulary Angiotensin-converting enzyme inhibitors->QUINAPRIL->With

ACEBUTOLOL Non Formulary 2.4 Beta-adrenoceptor blocking drugs

2.8 and protamine->2.8.2 Oral ACENOCOUMAROL Non Formulary anticoagulants->Coumarins and phenindione

ACIPIMOX Non Formulary 2.12 Lipid-regulating drugs->Nicotinic acid group

2.5 Hypertension and heart failure->2.5.1 Vasodilator Adcirca® Non Formulary antihypertensive drugs->TADALAFIL

2.5 Hypertension and heart failure->2.5.1 Vasodilator Adempas® Non Formulary antihypertensive drugs->RIOCIGUAT

Aggrastat® Non Formulary 2.9 Antiplatelet drugs->TIROFIBAN

2.5 Hypertension and heart failure->2.5.2 Centrally Aldomet® Non Formulary acting antihypertensive drugs->METHYLDOPA

2.5 Hypertension and heart failure->2.5.5 Drugs ALISKIREN Non Formulary affecting the renin-angiotensin system->2.5.5.3 Renin inhibitors

2.5 Hypertension and heart failure->2.5.1 Vasodilator AMBRISENTAN Non Formulary antihypertensive drugs

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Amias® Non Formulary Angiotensin-II receptor antagonists->CANDESARTAN CILEXETIL 2.2 ->2.2.3 Potassium-sparing diuretics and Amiloride Non Formulary aldosterone antagonists->AMILORIDE HYDROCHLORIDE

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and AMILORIDE HYDROCHLORIDE Non Formulary aldosterone antagonists

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Amiloride with bumetanide Non Formulary other diuretics

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Amiloride with bumetanide Non Formulary other diuretics->Amiloride with bumetanide

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Amiloride with cyclopenthiazide Non Formulary other diuretics

2.6 , -channel blockers, and other Angitak® Non Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE DINITRATE->Short-acting tablets and sprays

2.5 Hypertension and heart failure->2.5.1 Vasodilator Apresoline® Non Formulary antihypertensive drugs->HYDRALAZINE HYDROCHLORIDE

2.8 Anticoagulants and protamine->2.8.1 Parenteral Argatroban Non Formulary anticoagulants

2.8 Anticoagulants and protamine->2.8.1 Parenteral ARGATROBAN MONOHYDRATE Non Formulary anticoagulants->Argatroban

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Arythmol® Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias->PROPAFENONE HYDROCHLORIDE

Asasantin® Retard Non Formulary 2.9 Antiplatelet drugs->DIPYRIDAMOLE->With aspirin

2.5 Hypertension and heart failure->2.5.5 Drugs AZILSARTAN MEDOXOMIL Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

Bendroflumethiazide formulations 2.2 Diuretics->2.2.1 Thiazides and related Non Formulary [unlicensed] diuretics->BENDROFLUMETHIAZIDE

2.4 Beta-adrenoceptor blocking Beta-Adalat® Non Formulary drugs->ATENOLOL->With calcium-channel blocker

2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Betaloc® Non Formulary TARTRATE 2.5 Hypertension and heart failure->2.5.1 Vasodilator BOSENTAN Non Formulary antihypertensive drugs

2.5 Hypertension and heart failure->2.5.5 Drugs CANDESARTAN CILEXETIL Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Capoten® Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->CAPTOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Capozide® Non Formulary Angiotensin-converting enzyme inhibitors->CAPTOPRIL->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs CAPTOPRIL Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Captopril Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->CAPTOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Captopril formulations [unlicensed] Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->CAPTOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Carace Plus® Non Formulary Angiotensin-converting enzyme inhibitors->LISINOPRIL->With diuretic

2.5 Hypertension and heart failure->2.5.4 Cardura® XL Non Formulary Alpha-adrenoceptor blocking drugs->DOXAZOSIN->Modified-release

CARVEDILOL Non Formulary 2.4 Beta-adrenoceptor blocking drugs

Carvedilol Non Formulary 2.4 Beta-adrenoceptor blocking drugs->CARVEDILOL

2.4 Beta-adrenoceptor blocking drugs->CELIPROLOL Celectol® Non Formulary HYDROCHLORIDE

2.4 Beta-adrenoceptor blocking drugs->CELIPROLOL Celiprolol Non Formulary HYDROCHLORIDE

CELIPROLOL HYDROCHLORIDE Non Formulary 2.4 Beta-adrenoceptor blocking drugs CHLORTALIDONE Non Formulary 2.2 Diuretics->2.2.1 Thiazides and related diuretics

2.12 Lipid-regulating drugs->Bile acid Cholestagel® Non Formulary sequestrants->COLESEVELAM HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other CILOSTAZOL Non Formulary antianginal drugs->2.6.4 Peripheral vasodilators and TA223 http://www.nice.org.uk/TA223 related drugs

CIPROFIBRATE Non Formulary 2.12 Lipid-regulating drugs->Fibrates

Ciprofibrate Non Formulary 2.12 Lipid-regulating drugs->Fibrates->CIPROFIBRATE

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with CO-AMILOZIDE Non Formulary other diuretics

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Co-amilozide Non Formulary other diuretics->CO-AMILOZIDE

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Co-Diovan® Non Formulary Angiotensin-II receptor antagonists->VALSARTAN->With diuretic

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Co-flumactone Non Formulary other diuretics->Spironolactone with thiazides

CO-TENIDONE Non Formulary 2.4 Beta-adrenoceptor blocking drugs

Co-tenidone Non Formulary 2.4 Beta-adrenoceptor blocking drugs->CO-TENIDONE

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Co-triamterzide Non Formulary other diuretics->Triamterene with thiazides

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Co-zidocapt Non Formulary Angiotensin-converting enzyme inhibitors->CAPTOPRIL->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 CoAprovel® Non Formulary Angiotensin-II receptor antagonists->IRBESARTAN->With diuretic

COLESEVELAM HYDROCHLORIDE Non Formulary 2.12 Lipid-regulating drugs->Bile acid sequestrants

2.12 Lipid-regulating drugs->Bile acid Colestid® Non Formulary sequestrants->COLESTIPOL HYDROCHLORIDE

COLESTIPOL HYDROCHLORIDE Non Formulary 2.12 Lipid-regulating drugs->Bile acid sequestrants COLESTYRAMINE Non Formulary 2.12 Lipid-regulating drugs->Bile acid sequestrants

2.12 Lipid-regulating drugs->Bile acid Colestyramine Non Formulary sequestrants->COLESTYRAMINE

Compound preparations with 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Non Formulary thiazide or loop diuretics aldosterone antagonists->AMILORIDE HYDROCHLORIDE

Compound preparations with 2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Non Formulary thiazides or loop diuretics aldosterone antagonists->TRIAMTERENE

Corgard® Non Formulary 2.4 Beta-adrenoceptor blocking drugs->NADOLOL

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Coversyl® Arginine Non Formulary Angiotensin-converting enzyme inhibitors->PERINDOPRIL ARGININE

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Coversyl® Arginine Plus Non Formulary Angiotensin-converting enzyme inhibitors->PERINDOPRIL ARGININE->Perindopril arginine with diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Cozaar-Comp® Non Formulary Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM->With diuretic

Crestor® Non Formulary 2.12 Lipid-regulating drugs->Statins->ROSUVASTATIN

CYCLOPENTHIAZIDE Non Formulary 2.2 Diuretics->2.2.1 Thiazides and related diuretics

2.8 Anticoagulants and protamine->2.8.1 Parenteral DANAPAROID SODIUM Non Formulary anticoagulants->Heparinoids

2.11 drugs and Dicynene® Non Formulary haemostatics->ETAMSYLATE

2.1 Positive inotropic drugs->2.1.1 Cardiac DigiFab® Non Formulary glycosides->Digoxin-specific antibody

Digoxin-specific antibody Non Formulary 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides

2.5 Hypertension and heart failure->2.5.5 Drugs Diovan® Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->VALSARTAN 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for DISOPYRAMIDE Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Disopyramide Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias->DISOPYRAMIDE

Diumide-K Continus® Non Formulary 2.2 Diuretics->2.2.8 Diuretics with potassium

2.2 Diuretics->2.2.1 Thiazides and related Diurexan® Non Formulary diuretics->XIPAMIDE

2.5 Hypertension and heart failure->2.5.4 Doralese® Non Formulary Alpha-adrenoceptor blocking drugs->INDORAMIN

2.5 Hypertension and heart failure->2.5.4 Non Formulary Alpha-adrenoceptor blocking drugs->DOXAZOSIN->Modified-release

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for DRONEDARONE Non Formulary TA197 http://www.nice.org.uk/TA197 arrhythmias->Supraventricular arrhythmias

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Dyazide® Non Formulary other diuretics->Triamterene with thiazides

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Edarbi® Non Formulary Angiotensin-II receptor antagonists->AZILSARTAN MEDOXOMIL

2.6 Nitrates, calcium-channel blockers, and other Elantan LA® Non Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

2.8 Anticoagulants and protamine->2.8.1 Parenteral ENOXAPARIN SODIUM Non Formulary anticoagulants->Low molecular weight heparins

2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase ENOXIMONE Non Formulary type-3 inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs EPROSARTAN Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

EPTIFIBATIDE Non Formulary 2.9 Antiplatelet drugs

ESMOLOL HYDROCHLORIDE Non Formulary 2.4 Beta-adrenoceptor blocking drugs ETAMSYLATE Non Formulary 2.11 Antifibrinolytic drugs and haemostatics

2.8 Anticoagulants and protamine->2.8.1 Parenteral Exembol® Non Formulary anticoagulants->Argatroban->ARGATROBAN MONOHYDRATE

2.6 Nitrates, calcium-channel blockers, and other Exforge® Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->AMLODIPINE->With valsartan

2.6 Nitrates, calcium-channel blockers, and other FELODIPINE Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Felodipine Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->FELODIPINE

FENOFIBRATE Non Formulary 2.12 Lipid-regulating drugs->Fibrates

Fenofibrate Non Formulary 2.12 Lipid-regulating drugs->Fibrates->FENOFIBRATE

FLUVASTATIN Non Formulary 2.12 Lipid-regulating drugs->Statins

Fluvastatin Non Formulary 2.12 Lipid-regulating drugs->Statins->FLUVASTATIN

2.12 Lipid-regulating Fluvastatin Non Formulary drugs->Statins->FLUVASTATIN->Modified release

2.5 Hypertension and heart failure->2.5.5 Drugs FOSINOPRIL SODIUM Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Fosinopril sodium Non Formulary Angiotensin-converting enzyme inhibitors->FOSINOPRIL SODIUM

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Frusene® Non Formulary other diuretics->TRIAMTERENE WITH FUROSEMIDE

GEMFIBROZIL Non Formulary 2.12 Lipid-regulating drugs->Fibrates

Gemfibrozil Non Formulary 2.12 Lipid-regulating drugs->Fibrates->GEMFIBROZIL

2.5 Hypertension and heart failure->2.5.3 Adrenergic GUANETHIDINE MONOSULFATE Non Formulary neurone blocking drugs

2.5 Hypertension and heart failure->2.5.3 Adrenergic Guanethidine Monosulfate Non Formulary neurone blocking drugs->GUANETHIDINE MONOSULFATE 2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparin Calcium Non Formulary anticoagulants->Heparin->HEPARIN

2.6 Nitrates, calcium-channel blockers, and other Hexopal® Non Formulary antianginal drugs->2.6.4 Peripheral vasodilators and related drugs->INOSITOL NICOTINATE

2.5 Hypertension and heart failure->2.5.1 Vasodilator Non Formulary antihypertensive drugs->HYDRALAZINE HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.1 Vasodilator HYDRALAZINE HYDROCHLORIDE Non Formulary antihypertensive drugs

2.5 Hypertension and heart failure->2.5.1 Vasodilator Hydralazine hydrochloride Non Formulary antihypertensive drugs->HYDRALAZINE formulations [unlicensed] HYDROCHLORIDE

2.2 Diuretics->2.2.1 Thiazides and related Hygroton® Non Formulary diuretics->CHLORTALIDONE

2.5 Hypertension and heart failure->2.5.4 Hypovase® Non Formulary Alpha-adrenoceptor blocking drugs->PRAZOSIN

2.5 Hypertension and heart failure->2.5.4 Hytrin® Non Formulary Alpha-adrenoceptor blocking drugs->TERAZOSIN

2.5 Hypertension and heart failure->2.5.1 Vasodilator ILOPROST Non Formulary antihypertensive drugs

2.5 Hypertension and heart failure->2.5.5 Drugs IMIDAPRIL HYDROCHLORIDE Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.4 Non Formulary Alpha-adrenoceptor blocking drugs

2.5 Hypertension and heart failure->2.5.4 Indoramin Non Formulary Alpha-adrenoceptor blocking drugs->INDORAMIN

2.12 Lipid-regulating Inegy® Non Formulary drugs->Statins->SIMVASTATIN->With ezetimibe

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Innozide® Non Formulary Angiotensin-converting enzyme inhibitors->ENALAPRIL MALEATE->With diuretic 2.6 Nitrates, calcium-channel blockers, and other INOSITOL NICOTINATE Non Formulary antianginal drugs->2.6.4 Peripheral vasodilators and TA223 http://www.nice.org.uk/TA223 related drugs

Integrilin® Non Formulary 2.9 Antiplatelet drugs->EPTIFIBATIDE

2.6 Nitrates, calcium-channel blockers, and other Ismo Retard® Non Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Isodur® Non Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Isoket Retard® Non Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE DINITRATE->Modified-release preparations

2.6 Nitrates, calcium-channel blockers, and other Isoket® Non Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE DINITRATE->Parenteral preparations

2.6 Nitrates, calcium-channel blockers, and other ISOSORBIDE DINITRATE Non Formulary antianginal drugs->2.6.1 Nitrates

2.6 Nitrates, calcium-channel blockers, and other Isosorbide Dinitrate Non Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE DINITRATE->Short-acting tablets and sprays

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Kalspare® Non Formulary other diuretics->Triamterene with thiazides

2.4 Beta-adrenoceptor blocking Kalten® Non Formulary drugs->ATENOLOL->With diuretic

2.6 Nitrates, calcium-channel blockers, and other LACIDIPINE Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Lasilactone® Non Formulary other diuretics->Spironolactone with loop diuretics

2.6 Nitrates, calcium-channel blockers, and other LERCANIDIPINE HYDROCHLORIDE Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Lercanidipine Hydrochloride Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->LERCANIDIPINE HYDROCHLORIDE

Lescol® Non Formulary 2.12 Lipid-regulating drugs->Statins->FLUVASTATIN 2.12 Lipid-regulating Lescol® XL Non Formulary drugs->Statins->FLUVASTATIN->Modified release

Lipantil® Non Formulary 2.12 Lipid-regulating drugs->Fibrates->FENOFIBRATE

Lojuxta Non Formulary 2.12 Lipid-regulating drugs->Lomitapide->LOMITAPIDE

LOMITAPIDE Non Formulary 2.12 Lipid-regulating drugs->Lomitapide

2.5 Hypertension and heart failure->2.5.1 Vasodilator Loniten® Non Formulary antihypertensive drugs->MINOXIDIL

Lopid® Non Formulary 2.12 Lipid-regulating drugs->Fibrates->GEMFIBROZIL

2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Lopresor SR® Non Formulary TARTRATE->Modified release

2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Lopresor® Non Formulary TARTRATE

2.5 Hypertension and heart failure->2.5.5 Drugs Losartan potassium with affecting the renin-angiotensin system->2.5.5.2 Non Formulary hydrochlorothiazide Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM->With diuretic

2.5 Hypertension and heart failure->2.5.1 Vasodilator MACITENTAN Non Formulary antihypertensive drugs

2.5 Hypertension and heart failure->2.5.2 Centrally Non Formulary acting antihypertensive drugs

2.5 Hypertension and heart failure->2.5.2 Centrally Methyldopa Non Formulary acting antihypertensive drugs->METHYLDOPA

Methyldopa formulations 2.5 Hypertension and heart failure->2.5.2 Centrally Non Formulary [unlicensed] acting antihypertensive drugs->METHYLDOPA

METOPROLOL TARTRATE Non Formulary 2.4 Beta-adrenoceptor blocking drugs

2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Metoprolol Tartrate Non Formulary TARTRATE

Metoprolol tartrate formulations 2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Non Formulary [unlicensed] TARTRATE

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Micardis Plus® Non Formulary Angiotensin-II receptor antagonists->TELMISARTAN->With diuretic 2.5 Hypertension and heart failure->2.5.5 Drugs Micardis® Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->TELMISARTAN

2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase MILRINONE Non Formulary type-3 inhibitors

2.5 Hypertension and heart failure->2.5.1 Vasodilator Non Formulary antihypertensive drugs

2.5 Hypertension and heart failure->2.5.1 Vasodilator Minoxidil formulations [unlicensed] Non Formulary antihypertensive drugs->MINOXIDIL

2.5 Hypertension and heart failure->2.5.4 Modified-release Non Formulary Alpha-adrenoceptor blocking drugs->DOXAZOSIN

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Modified release Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias->DISOPYRAMIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Modified release Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias->FLECAINIDE ACETATE

2.4 Beta-adrenoceptor blocking drugs->METOPROLOL Modified release Non Formulary TARTRATE

2.4 Beta-adrenoceptor blocking drugs->OXPRENOLOL Modified release Non Formulary HYDROCHLORIDE

Modified release Non Formulary 2.12 Lipid-regulating drugs->Statins->FLUVASTATIN

2.5 Hypertension and heart failure->2.5.5 Drugs MOEXIPRIL HYDROCHLORIDE Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.6 Nitrates, calcium-channel blockers, and other Motens® Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->LACIDIPINE

2.6 Nitrates, calcium-channel blockers, and other Non Formulary antianginal drugs->2.6.4 Peripheral vasodilators and related drugs

2.5 Hypertension and heart failure->2.5.2 Centrally MOXONIDINE Non Formulary acting antihypertensive drugs

2.5 Hypertension and heart failure->2.5.2 Centrally Moxonidine Non Formulary acting antihypertensive drugs->MOXONIDINE 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Multaq® Non Formulary arrhythmias->Supraventricular arrhythmias->DRONEDARONE

NADOLOL Non Formulary 2.4 Beta-adrenoceptor blocking drugs

2.2 Diuretics->2.2.1 Thiazides and related Navidrex® Non Formulary diuretics->CYCLOPENTHIAZIDE

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Navispare® Non Formulary other diuretics->Amiloride with cyclopenthiazide

Nebilet® Non Formulary 2.4 Beta-adrenoceptor blocking drugs->NEBIVOLOL

NEBIVOLOL Non Formulary 2.4 Beta-adrenoceptor blocking drugs

Nebivolol Non Formulary 2.4 Beta-adrenoceptor blocking drugs->NEBIVOLOL

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for new item Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias->AMIODARONE HYDROCHLORIDE

2.12 Lipid-regulating drugs->Nicotinic acid Niaspan® Non Formulary group->NICOTINIC ACID->Modified release

NICOTINIC ACID Non Formulary 2.12 Lipid-regulating drugs->Nicotinic acid group

2.6 Nitrates, calcium-channel blockers, and other Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE

2.6 Nitrates, calcium-channel blockers, and other NIMODIPINE Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Nimotop® Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIMODIPINE

2.5 Hypertension and heart failure->2.5.5 Drugs Noyada® Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->CAPTOPRIL

2.12 Lipid-regulating drugs->Nicotinic acid Olbetam® Non Formulary group->ACIPIMOX

2.5 Hypertension and heart failure->2.5.5 Drugs OLMESARTAN MEDOXOMIL Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists 2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Olmetec Plus® Non Formulary Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL->With diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Olmetec® Non Formulary Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL

2.12 Lipid-regulating drugs->Omega-3 fatty acid Omacor® Non Formulary compounds->OMEGA-3-ACID ETHYL ESTERS

2.12 Lipid-regulating drugs->Omega-3 fatty acid OMEGA-3-ACID ETHYL ESTERS Non Formulary compounds

2.6 Nitrates, calcium-channel blockers, and other Opilon® Non Formulary antianginal drugs->2.6.4 Peripheral vasodilators and related drugs->MOXISYLYTE

2.5 Hypertension and heart failure->2.5.1 Vasodilator Opsumit® Non Formulary antihypertensive drugs->MACITENTAN

2.8 Anticoagulants and protamine->2.8.1 Parenteral Orgaran® Non Formulary anticoagulants->Heparinoids->DANAPAROID SODIUM

2.4 Beta-adrenoceptor blocking drugs->OXPRENOLOL Oxprenolol Non Formulary HYDROCHLORIDE

OXPRENOLOL HYDROCHLORIDE Non Formulary 2.4 Beta-adrenoceptor blocking drugs

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.4 Peripheral vasodilators and Paroven® Non Formulary related drugs->Other preparations used in peripheral vascular disease

2.5 Hypertension and heart failure->2.5.1 Vasodilator PENTOLINIUM Non Formulary PENTOLINIUM 10mg/2ml injection. For controlled in surgery. UNLICENSED. antihypertensive drugs

2.6 Nitrates, calcium-channel blockers, and other Percutol® Non Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Transdermal preparations

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Perdix® Non Formulary Angiotensin-converting enzyme inhibitors->MOEXIPRIL HYDROCHLORIDE 2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase Perfan® Non Formulary type-3 inhibitors->ENOXIMONE

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Perindopril Non Formulary Angiotensin-converting enzyme inhibitors->PERINDOPRIL ERBUMINE

2.5 Hypertension and heart failure->2.5.5 Drugs PERINDOPRIL ARGININE Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Perindopril arginine with diuretic Non Formulary Angiotensin-converting enzyme inhibitors->PERINDOPRIL ARGININE

2.5 Hypertension and heart failure->2.5.5 Drugs PERINDOPRIL ERBUMINE Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.8 Anticoagulants and protamine->2.8.2 Oral PHENINDIONE Non Formulary anticoagulants->Coumarins and phenindione

2.8 Anticoagulants and protamine->2.8.2 Oral Phenindione Non Formulary anticoagulants->Coumarins and phenindione->PHENINDIONE

2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking Non Formulary drugs->Phaeochromocytoma->PHENOXYBENZAMINE HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.4 PHENOXYBENZAMINE Non Formulary Alpha-adrenoceptor blocking HYDROCHLORIDE drugs->Phaeochromocytoma

2.5 Hypertension and heart failure->2.5.2 Centrally Physiotens® Non Formulary acting antihypertensive drugs->MOXONIDINE

PINDOLOL Non Formulary 2.4 Beta-adrenoceptor blocking drugs

Pindolol Non Formulary 2.4 Beta-adrenoceptor blocking drugs->PINDOLOL

Plavix® Non Formulary 2.9 Antiplatelet drugs->CLOPIDOGREL

2.6 Nitrates, calcium-channel blockers, and other Plendil® Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->FELODIPINE 2.6 Nitrates, calcium-channel blockers, and other Pletal® Non Formulary antianginal drugs->2.6.4 Peripheral vasodilators and related drugs->CILOSTAZOL

2.5 Hypertension and heart failure->2.5.4 Non Formulary Alpha-adrenoceptor blocking drugs

2.5 Hypertension and heart failure->2.5.4 Prazosin Non Formulary Alpha-adrenoceptor blocking drugs->PRAZOSIN

2.4 Beta-adrenoceptor blocking drugs->TIMOLOL Prestim® Non Formulary MALEATE->With diuretic

2.12 Lipid-regulating drugs->Omega-3 fatty acid Prestylon® Non Formulary compounds->OMEGA-3-ACID ETHYL ESTERS

2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase Primacor® Non Formulary type-3 inhibitors->MILRINONE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for HYDROCHLORIDE Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias

2.12 Lipid-regulating drugs->Bile acid Questran Light® Non Formulary sequestrants->COLESTYRAMINE

2.12 Lipid-regulating drugs->Bile acid Questran® Non Formulary sequestrants->COLESTYRAMINE

2.5 Hypertension and heart failure->2.5.5 Drugs QUINAPRIL Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Quinapril Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->QUINAPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs RAMIPRIL WITH FELODIPINE Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.6 Nitrates, calcium-channel blockers, and other Ranexa® Non Formulary antianginal drugs->2.6.3 Other antianginal drugs->RANOLAZINE

2.6 Nitrates, calcium-channel blockers, and other RANOLAZINE Non Formulary antianginal drugs->2.6.3 Other antianginal drugs 2.10 Stable , acute coronary syndromes, and Rapilysin® Non Formulary fibrinolysis->2.10.2 Fibrinolytic drugs->RETEPLASE

2.5 Hypertension and heart failure->2.5.5 Drugs Rasilez® Non Formulary affecting the renin-angiotensin system->2.5.5.3 Renin inhibitors->ALISKIREN

ReoPro® Non Formulary 2.9 Antiplatelet drugs->ABCIXIMAB

2.10 Stable angina, acute coronary syndromes, and RETEPLASE Non Formulary fibrinolysis->2.10.2 Fibrinolytic drugs

2.5 Hypertension and heart failure->2.5.1 Vasodilator Revatio® Non Formulary antihypertensive drugs->SILDENAFIL

2.5 Hypertension and heart failure->2.5.1 Vasodilator RIOCIGUAT Non Formulary antihypertensive drugs

ROSUVASTATIN Non Formulary 2.12 Lipid-regulating drugs->Statins

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Rythmodan Retard® Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias->DISOPYRAMIDE->Modified release

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Rythmodan® Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias->DISOPYRAMIDE

Sectral® Non Formulary 2.4 Beta-adrenoceptor blocking drugs->ACEBUTOLOL

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Sevikar HCT® Non Formulary Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL->With calcium-channel blocker and diuretic

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Sevikar® Non Formulary Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL->With calcium-channel blocker

2.5 Hypertension and heart failure->2.5.1 Vasodilator SILDENAFIL Non Formulary antihypertensive drugs

2.5 Hypertension and heart failure->2.5.1 Vasodilator Sildenafil formulations [unlicensed] Non Formulary antihypertensive drugs->SILDENAFIL

2.8 Anticoagulants and protamine->2.8.2 Oral Sinthrome® Non Formulary anticoagulants->Coumarins and phenindione->ACENOCOUMAROL 2.4 Beta-adrenoceptor blocking drugs->OXPRENOLOL Slow-Trasicor® Non Formulary HYDROCHLORIDE->Modified release

2.5 Hypertension and heart failure->2.5.1 Vasodilator Non Formulary antihypertensive drugs

2.5 Hypertension and heart failure->2.5.1 Vasodilator Sodium Nitroprusside Non Formulary antihypertensive drugs->SODIUM NITROPRUSSIDE

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Spironolactone with loop diuretics Non Formulary other diuretics

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Spironolactone with thiazides Non Formulary other diuretics

Supralip® 160 Non Formulary 2.12 Lipid-regulating drugs->Fibrates->FENOFIBRATE

2.10 Stable angina, acute coronary syndromes, and Syner-KINASE® Non Formulary fibrinolysis->2.10.2 Fibrinolytic drugs->UROKINASE

2.5 Hypertension and heart failure->2.5.1 Vasodilator TADALAFIL Non Formulary antihypertensive drugs

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Tambocor® XL Non Formulary arrhythmias->Supraventricular and ventricular arrhythmias->FLECAINIDE ACETATE->Modified release

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Tanatril® Non Formulary Angiotensin-converting enzyme inhibitors->IMIDAPRIL HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.5 Drugs TELMISARTAN Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

2.4 Beta-adrenoceptor blocking Tenif® Non Formulary drugs->ATENOLOL->With calcium-channel blocker

Tenoret 50® Non Formulary 2.4 Beta-adrenoceptor blocking drugs->CO-TENIDONE

Tenoretic® Non Formulary 2.4 Beta-adrenoceptor blocking drugs->CO-TENIDONE

2.5 Hypertension and heart failure->2.5.4 Non Formulary Alpha-adrenoceptor blocking drugs

2.5 Hypertension and heart failure->2.5.4 Terazosin Non Formulary Alpha-adrenoceptor blocking drugs->TERAZOSIN 2.5 Hypertension and heart failure->2.5.5 Drugs Teveten® Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->EPROSARTAN

TIMOLOL MALEATE Non Formulary 2.4 Beta-adrenoceptor blocking drugs

Timolol with amiloride and 2.4 Beta-adrenoceptor blocking drugs->TIMOLOL Non Formulary hydrochlorothiazide MALEATE->With diuretic

2.8 Anticoagulants and protamine->2.8.1 Parenteral TINZAPARIN SODIUM Non Formulary anticoagulants->Low molecular weight heparins

TIROFIBAN Non Formulary 2.9 Antiplatelet drugs

TORASEMIDE Non Formulary 2.2 Diuretics->2.2.2 Loop diuretics

Torasemide Non Formulary 2.2 Diuretics->2.2.2 Loop diuretics->TORASEMIDE

Torem® Non Formulary 2.2 Diuretics->2.2.2 Loop diuretics->TORASEMIDE

2.5 Hypertension and heart failure->2.5.1 Vasodilator Tracleer® Non Formulary antihypertensive drugs->BOSENTAN

2.5 Hypertension and heart failure->2.5.5 Drugs TRANDOLAPRIL Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Trandolapril Non Formulary Angiotensin-converting enzyme inhibitors->TRANDOLAPRIL

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and TRIAMTERENE Non Formulary aldosterone antagonists

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Triamterene Non Formulary aldosterone antagonists->TRIAMTERENE

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with TRIAMTERENE WITH FUROSEMIDE Non Formulary other diuretics

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Triamterene with thiazides Non Formulary other diuretics

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Triapin® Non Formulary Angiotensin-converting enzyme inhibitors->RAMIPRIL WITH FELODIPINE 2.10 Stable angina, acute coronary syndromes, and UROKINASE Non Formulary fibrinolysis->2.10.2 Fibrinolytic drugs

2.10 Stable angina, acute coronary syndromes, and Urokinase Non Formulary fibrinolysis->2.10.2 Fibrinolytic drugs->UROKINASE

2.5 Hypertension and heart failure->2.5.5 Drugs VALSARTAN Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Valsartan Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->VALSARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Valsartan with hydrochlorothiazide Non Formulary Angiotensin-II receptor antagonists->VALSARTAN->With diuretic

2.5 Hypertension and heart failure->2.5.1 Vasodilator Ventavis® Non Formulary antihypertensive drugs->ILOPROST

2.6 Nitrates, calcium-channel blockers, and other hydrochloride Non Formulary antianginal drugs->2.6.2 Calcium-channel formulations [unlicensed] blockers->VERAPAMIL HYDROCHLORIDE

2.4 Beta-adrenoceptor blocking Viskaldix® Non Formulary drugs->PINDOLOL->With diuretic

Visken® Non Formulary 2.4 Beta-adrenoceptor blocking drugs->PINDOLOL

2.5 Hypertension and heart failure->2.5.1 Vasodilator Volibris® Non Formulary antihypertensive drugs->AMBRISENTAN

With aspirin Non Formulary 2.9 Antiplatelet drugs->DIPYRIDAMOLE

2.6 Nitrates, calcium-channel blockers, and other With atenolol Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE

With calcium-channel blocker Non Formulary 2.4 Beta-adrenoceptor blocking drugs->ATENOLOL

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 With calcium-channel blocker Non Formulary Angiotensin-II receptor antagonists->OLMESARTAN MEDOXOMIL

With diuretic Non Formulary 2.4 Beta-adrenoceptor blocking drugs->ATENOLOL With diuretic Non Formulary 2.4 Beta-adrenoceptor blocking drugs->PINDOLOL

2.4 Beta-adrenoceptor blocking drugs->TIMOLOL With diuretic Non Formulary MALEATE

2.5 Hypertension and heart failure->2.5.5 Drugs With diuretic Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->CAPTOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 With diuretic Non Formulary Angiotensin-converting enzyme inhibitors->ENALAPRIL MALEATE

2.5 Hypertension and heart failure->2.5.5 Drugs With diuretic Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->LISINOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs With diuretic Non Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->QUINAPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs With diuretic Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->IRBESARTAN

2.5 Hypertension and heart failure->2.5.5 Drugs With diuretic Non Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->TELMISARTAN

With ezetimibe Non Formulary 2.12 Lipid-regulating drugs->Statins->SIMVASTATIN

2.6 Nitrates, calcium-channel blockers, and other With ramipril Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->FELODIPINE

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and With thiazides or loop diuretics Non Formulary aldosterone antagonists->Aldosterone antagonists->SPIRONOLACTONE

XIPAMIDE Non Formulary 2.2 Diuretics->2.2.1 Thiazides and related diuretics

2.6 Nitrates, calcium-channel blockers, and other Zanidip® Non Formulary antianginal drugs->2.6.2 Calcium-channel blockers->LERCANIDIPINE HYDROCHLORIDE 2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Zestoretic® Non Formulary Angiotensin-converting enzyme inhibitors->LISINOPRIL->With diuretic

2.6 Nitrates, calcium-channel blockers, and other Adalat® On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE

2.6 Nitrates, calcium-channel blockers, and other Adalat® LA On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Adalat® Retard On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Adenocor® On Formulary arrhythmias->Supraventricular arrhythmias->ADENOSINE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Adenoscan® On Formulary arrhythmias->Supraventricular arrhythmias->ADENOSINE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for ADENOSINE On Formulary arrhythmias->Supraventricular arrhythmias

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Adenosine On Formulary arrhythmias->Supraventricular arrhythmias->ADENOSINE

2.6 Nitrates, calcium-channel blockers, and other Adipine® MR On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Adipine® XL On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Adizem-SR® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations 2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Adizem-XL® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.7 Sympathomimetics->2.7.3 Cardiopulmonary /EPINEPHRINE On Formulary resuscitation

Adrenaline/Epinephrine 1 in 2.7 Sympathomimetics->2.7.3 Cardiopulmonary On Formulary 10 000, Dilute resuscitation->ADRENALINE/EPINEPHRINE

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Aldactone® On Formulary aldosterone antagonists->Aldosterone antagonists->SPIRONOLACTONE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Amiodarone On Formulary arrhythmias->Supraventricular and ventricular arrhythmias->AMIODARONE HYDROCHLORIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for AMIODARONE HYDROCHLORIDE On Formulary arrhythmias->Supraventricular and ventricular Amiodarone Guidelines arrhythmias

2.6 Nitrates, calcium-channel blockers, and other On Formulary 1st Line Calcium-channel blocker for hypertension antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Amlodipine On Formulary antianginal drugs->2.6.2 Calcium-channel 1st Line for hypertension blockers->AMLODIPINE

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Angitil SR® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Angitil XL® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.5 Hypertension and heart failure->2.5.5 Drugs Aprovel® On Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->IRBESARTAN

Aspirin On Formulary 2.9 Antiplatelet drugs->ASPIRIN (antiplatelet)

ASPIRIN (antiplatelet) On Formulary 2.9 Antiplatelet drugs

ATENOLOL On Formulary 2.4 Beta-adrenoceptor blocking drugs 1st Line Beta-blocker for angina and hypertension. Atenolol On Formulary 2.4 Beta-adrenoceptor blocking drugs->ATENOLOL 1st Line Beta-blocker for angina and hypertension

ATORVASTATIN On Formulary 2.12 Lipid-regulating drugs->Statins

Atorvastatin On Formulary 2.12 Lipid-regulating drugs->Statins->ATORVASTATIN

BENDROFLUMETHIAZIDE On Formulary 2.2 Diuretics->2.2.1 Thiazides and related diuretics

2.2 Diuretics->2.2.1 Thiazides and related Bendroflumethiazide On Formulary diuretics->BENDROFLUMETHIAZIDE

2.4 Beta-adrenoceptor blocking drugs->SOTALOL Beta-Cardone® On Formulary HYDROCHLORIDE

BEZAFIBRATE On Formulary 2.12 Lipid-regulating drugs->Fibrates 1st Line

Bezafibrate On Formulary 2.12 Lipid-regulating drugs->Fibrates->BEZAFIBRATE 1st Line Fibrate

2.12 Lipid-regulating Bezafibrate On Formulary 1st Line Fibrate drugs->Fibrates->BEZAFIBRATE->Modified release

Bezalip® On Formulary 2.12 Lipid-regulating drugs->Fibrates->BEZAFIBRATE 1st Line Fibrate

2.12 Lipid-regulating Bezalip® Mono On Formulary 1st Line Fibrate drugs->Fibrates->BEZAFIBRATE->Modified release

BISOPROLOL FUMARATE On Formulary 2.4 Beta-adrenoceptor blocking drugs

2.4 Beta-adrenoceptor blocking drugs->BISOPROLOL Bisoprolol Fumarate On Formulary FUMARATE

2.4 Beta-adrenoceptor blocking drugs->ESMOLOL Brevibloc® On Formulary HYDROCHLORIDE

BUMETANIDE On Formulary 2.2 Diuretics->2.2.2 Loop diuretics

Bumetanide On Formulary 2.2 Diuretics->2.2.2 Loop diuretics->BUMETANIDE

2.4 Beta-adrenoceptor blocking drugs->BISOPROLOL Cardicor® On Formulary FUMARATE

2.5 Hypertension and heart failure->2.5.4 Cardura® On Formulary Alpha-adrenoceptor blocking drugs->DOXAZOSIN

2.6 Nitrates, calcium-channel blockers, and other Chemydur® 60XL On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

CLOPIDOGREL On Formulary 2.9 Antiplatelet drugs TA210 http://www.nice.org.uk/TA210 Clopidogrel Loading Doses

Clopidogrel On Formulary 2.9 Antiplatelet drugs->CLOPIDOGREL Generic brands used (not Plavix) 2.2 Diuretics->2.2.4 Potassium-sparing diuretics with CO-AMILOFRUSE On Formulary other diuretics

2.2 Diuretics->2.2.4 Potassium-sparing diuretics with Co-amilofruse On Formulary other diuretics->CO-AMILOFRUSE

2.6 Nitrates, calcium-channel blockers, and other Coracten SR® On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Coracten XL® On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Cordarone X® On Formulary arrhythmias->Supraventricular and ventricular arrhythmias->AMIODARONE HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Cordilox® On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->VERAPAMIL HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Coro-Nitro Pump Spray® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Short-acting tablets and sprays

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Cozaar® On Formulary 1st Line ACE-2 Receptor Antagonist Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM

2.11 Antifibrinolytic drugs and Mouthwash 5% for prevention of bleeding post-dental extraction in patients on oral Cyklokapron® On Formulary haemostatics->TRANEXAMIC ACID anticoagulants and where bleeding occurs post-op. UNLICENSED

2.11 Antifibrinolytic drugs and Mouthwash 5% for prevention of bleeding post-dental extraction in patients on oral Cyklokapron® On Formulary haemostatics->TRANEXAMIC ACID anticoagulants and where bleeding occurs post-op. UNLICENSED

2.8 Anticoagulants and protamine->2.8.2 Oral Dabigatran etexilate On Formulary Formulary for NICE indications as recommended by consultant haematologist. anticoagulants

2.8 Anticoagulants and protamine->2.8.2 Oral DABIGATRAN ETEXILATE On Formulary TA249 http://www.nice.org.uk/TA249 Formulary for NICE indications as recommended by consultant haematologist. anticoagulants->Dabigatran etexilate

2.8 Anticoagulants and protamine->2.8.2 Oral DABIGATRAN ETEXILATE On Formulary TA157 http://www.nice.org.uk/TA157 Formulary for NICE indications as recommended by consultant haematologist. anticoagulants->Dabigatran etexilate

2.8 Anticoagulants and protamine->2.8.2 Oral DABIGATRAN ETEXILATE On Formulary TA327 http://www.nice.org.uk/TA327 Formulary for NICE indications as recommended by consultant haematologist. anticoagulants->Dabigatran etexilate 2.8 Anticoagulants and protamine->2.8.1 Parenteral DALTEPARIN SODIUM On Formulary anticoagulants->Low molecular weight heparins

2.6 Nitrates, calcium-channel blockers, and other Deponit® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Transdermal preparations

DIGOXIN On Formulary 2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides

2.1 Positive inotropic drugs->2.1.1 Cardiac Digoxin On Formulary 1st Line glycosides->DIGOXIN

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Dilcardia SR® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Diltiazem On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Standard formulations

2.6 Nitrates, calcium-channel blockers, and other DILTIAZEM HYDROCHLORIDE On Formulary antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Dilzem SR® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Dilzem XL® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

DIPYRIDAMOLE On Formulary 2.9 Antiplatelet drugs TA210 http://www.nice.org.uk/TA210

Dipyridamole On Formulary 2.9 Antiplatelet drugs->DIPYRIDAMOLE

2.7 Sympathomimetics->2.7.1 Inotropic On Formulary sympathomimetics

2.7 Sympathomimetics->2.7.1 Inotropic Dobutamine On Formulary sympathomimetics->DOBUTAMINE

2.7 Sympathomimetics->2.7.1 Inotropic Dopacard® On Formulary sympathomimetics->DOPEXAMINE HYDROCHLORIDE 2.7 Sympathomimetics->2.7.1 Inotropic On Formulary sympathomimetics->DOPAMINE HYDROCHLORIDE

2.7 Sympathomimetics->2.7.1 Inotropic DOPAMINE HYDROCHLORIDE On Formulary sympathomimetics

2.7 Sympathomimetics->2.7.1 Inotropic HYDROCHLORIDE On Formulary sympathomimetics

2.5 Hypertension and heart failure->2.5.4 DOXAZOSIN On Formulary Alpha-adrenoceptor blocking drugs

2.5 Hypertension and heart failure->2.5.4 Doxazosin On Formulary Alpha-adrenoceptor blocking drugs->DOXAZOSIN

2.5 Hypertension and heart failure->2.5.5 Drugs ENALAPRIL MALEATE On Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Enalapril Maleate On Formulary Angiotensin-converting enzyme inhibitors->ENALAPRIL MALEATE

2.7 Sympathomimetics->2.7.2 Vasoconstrictor HYDROCHLORIDE On Formulary sympathomimetics

2.7 Sympathomimetics->2.7.2 Vasoconstrictor Ephedrine Hydrochloride On Formulary sympathomimetics->EPHEDRINE HYDROCHLORIDE

2.2 Diuretics->2.2.1 Thiazides and related Ethibide XL® On Formulary diuretics->INDAPAMIDE->Modified release

EZETIMIBE On Formulary 2.12 Lipid-regulating drugs->Ezetimibe TA132 http://www.nice.org.uk/TA132 Only if statins not tolerated

Ezetrol® On Formulary 2.12 Lipid-regulating drugs->Ezetimibe->EZETIMIBE Only if statins not tolerated

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Flecainide On Formulary arrhythmias->Supraventricular and ventricular arrhythmias->FLECAINIDE ACETATE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for FLECAINIDE ACETATE On Formulary arrhythmias->Supraventricular and ventricular arrhythmias

2.6 Nitrates, calcium-channel blockers, and other Fortipine LA 40® On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release 2.8 Anticoagulants and protamine->2.8.1 Parenteral Fragmin® On Formulary anticoagulants->Low molecular weight heparins->DALTEPARIN SODIUM

FUROSEMIDE On Formulary 2.2 Diuretics->2.2.2 Loop diuretics 1st Line Loop Diuretic

Furosemide On Formulary 2.2 Diuretics->2.2.2 Loop diuretics->FUROSEMIDE 1st Line Loop Diuretic

2.6 Nitrates, calcium-channel blockers, and other GLYCERYL TRINITRATE On Formulary antianginal drugs->2.6.1 Nitrates

2.6 Nitrates, calcium-channel blockers, and other Glyceryl Trinitrate On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Glyceryl Trinitrate On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Parenteral preparations

2.6 Nitrates, calcium-channel blockers, and other Glytrin Spray® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other GTN 300 mcg On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Half Securon SR® On Formulary blockers->VERAPAMIL HYDROCHLORIDE->Modified release

2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparin On Formulary Link - Heparin in BURNS anticoagulants

2.8 Anticoagulants and protamine->2.8.1 Parenteral HEPARIN On Formulary anticoagulants->Heparin

2.8 Anticoagulants and protamine->2.8.1 Parenteral Heparin Sodium On Formulary anticoagulants->Heparin->HEPARIN

2.6 Nitrates, calcium-channel blockers, and other Ikorel® On Formulary antianginal drugs->2.6.3 Other antianginal drugs->NICORANDIL

2.6 Nitrates, calcium-channel blockers, and other Imdur® On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release INDAPAMIDE On Formulary 2.2 Diuretics->2.2.1 Thiazides and related diuretics

2.2 Diuretics->2.2.1 Thiazides and related Indapamide On Formulary diuretics->INDAPAMIDE

2.8 Anticoagulants and protamine->2.8.1 Parenteral Innohep® On Formulary anticoagulants->Low molecular weight For SURGICAL thromboprophylaxis and DVT/PE treatment heparins->TINZAPARIN SODIUM

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Innovace® On Formulary Angiotensin-converting enzyme inhibitors->ENALAPRIL MALEATE

2.5 Hypertension and heart failure->2.5.5 Drugs IRBESARTAN On Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs Irbesartan On Formulary affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->IRBESARTAN

2.6 Nitrates, calcium-channel blockers, and other Isib 60XL® On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Ismo® On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE

2.6 Nitrates, calcium-channel blockers, and other Isosorbide Mononitrate On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE

2.6 Nitrates, calcium-channel blockers, and other Isotard® On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Istin® On Formulary antianginal drugs->2.6.2 Calcium-channel 1st Line Calcium channel blocker for hypertension blockers->AMLODIPINE

2.1 Positive inotropic drugs->2.1.1 Cardiac Lanoxin-PG® On Formulary glycosides->DIGOXIN

2.1 Positive inotropic drugs->2.1.1 Cardiac Lanoxin® On Formulary glycosides->DIGOXIN

Lasix® On Formulary 2.2 Diuretics->2.2.2 Loop diuretics->FUROSEMIDE 1st Line Loop Diuretic 2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Lidocaine On Formulary arrhythmias->Ventricular arrhythmias->LIDOCAINE HYDROCHLORIDE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for LIDOCAINE HYDROCHLORIDE On Formulary arrhythmias->Ventricular arrhythmias

Lipitor® On Formulary 2.12 Lipid-regulating drugs->Statins->ATORVASTATIN

2.5 Hypertension and heart failure->2.5.5 Drugs LISINOPRIL On Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Lisinopril On Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->LISINOPRIL

2.5 Hypertension and heart failure->2.5.5 Drugs Lisinopril formulations [unlicensed] On Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->LISINOPRIL

2.6 Nitrates, calcium-channel blockers, and other Longer-acting formulations On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->DILTIAZEM HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.5 Drugs LOSARTAN POTASSIUM On Formulary affecting the renin-angiotensin system->2.5.5.2 1st Line ACE-2 Receptor Antagonist Angiotensin-II receptor antagonists

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Losartan Potassium On Formulary Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM

MANNITOL On Formulary 2.2 Diuretics->2.2.5 Osmotic diuretics

Mannitol On Formulary 2.2 Diuretics->2.2.5 Osmotic diuretics->MANNITOL

2.10 Stable angina, acute coronary syndromes, and Metalyse® On Formulary 1st Line for MI. Kept on Burns Crash Trolley -NOT Pharmacy fibrinolysis->2.10.2 Fibrinolytic drugs->TENECTEPLASE

2.7 Sympathomimetics->2.7.2 Vasoconstrictor On Formulary UNLICENSED sympathomimetics

2.7 Sympathomimetics->2.7.2 Vasoconstrictor Metaraminol On Formulary UNLICENSED medication sympathomimetics->METARAMINOL

METOLAZONE On Formulary 2.2 Diuretics->2.2.1 Thiazides and related diuretics 2.2 Diuretics->2.2.1 Thiazides and related Metolazone On Formulary diuretics->METOLAZONE

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Minijet® Lignocaine On Formulary arrhythmias->Ventricular arrhythmias->LIDOCAINE HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Minitran® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Transdermal preparations

2.2 Diuretics->2.2.1 Thiazides and related Modified release On Formulary diuretics->INDAPAMIDE

2.4 Beta-adrenoceptor blocking drugs->PROPRANOLOL Modified release On Formulary HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Modified release On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE

2.6 Nitrates, calcium-channel blockers, and other Modified release On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE

2.6 Nitrates, calcium-channel blockers, and other Modified release On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->VERAPAMIL HYDROCHLORIDE

Modified release On Formulary 2.9 Antiplatelet drugs->DIPYRIDAMOLE

Modified release On Formulary 2.12 Lipid-regulating drugs->Fibrates->BEZAFIBRATE

2.6 Nitrates, calcium-channel blockers, and other Modisal XL® On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Monomax® On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Monomil XL® On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Monosorb XL 60® On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release 2.2 Diuretics->2.2.1 Thiazides and related Natrilix SR® On Formulary diuretics->INDAPAMIDE->Modified release

2.2 Diuretics->2.2.1 Thiazides and related Natrilix® On Formulary diuretics->INDAPAMIDE

2.6 Nitrates, calcium-channel blockers, and other On Formulary antianginal drugs->2.6.3 Other antianginal drugs

2.6 Nitrates, calcium-channel blockers, and other Nicorandil On Formulary antianginal drugs->2.6.3 Other antianginal drugs->NICORANDIL

2.6 Nitrates, calcium-channel blockers, and other Nifedipress® MR On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Nitro-Dur® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Transdermal preparations

2.6 Nitrates, calcium-channel blockers, and other Nitrocine® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Parenteral preparations

2.6 Nitrates, calcium-channel blockers, and other Nitrolingual Pumpspray® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Nitromin® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Short-acting tablets and sprays

2.6 Nitrates, calcium-channel blockers, and other Nitronal® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Parenteral preparations

2.7 Sympathomimetics->2.7.2 Vasoconstrictor NORADRENALINE/ On Formulary sympathomimetics

2.7 Sympathomimetics->2.7.2 Vasoconstrictor Noradrenaline/Norepinephrine On Formulary sympathomimetics->NORADRENALINE/NOREPINEPHRINE

Nu-Seals® Aspirin On Formulary 2.9 Antiplatelet drugs->ASPIRIN (antiplatelet)

2.6 Nitrates, calcium-channel blockers, and other Parenteral preparations On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE Persantin® On Formulary 2.9 Antiplatelet drugs->DIPYRIDAMOLE

2.9 Antiplatelet drugs->DIPYRIDAMOLE->Modified Persantin® Retard On Formulary release

2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking On Formulary drugs->Phaeochromocytoma->PHENTOLAMINE MESILATE

2.5 Hypertension and heart failure->2.5.4 PHENTOLAMINE MESILATE On Formulary Alpha-adrenoceptor blocking drugs->Phaeochromocytoma

2.7 Sympathomimetics->2.7.2 Vasoconstrictor On Formulary sympathomimetics->PHENYLEPHRINE HYDROCHLORIDE

2.7 Sympathomimetics->2.7.2 Vasoconstrictor PHENYLEPHRINE HYDROCHLORIDE On Formulary sympathomimetics

2.8 Anticoagulants and protamine->2.8.2 Oral Pradaxa® On Formulary anticoagulants->Dabigatran etexilate->DABIGATRAN Formulary for NICE indications as recommended by consultant haematologist. ETEXILATE

2.4 Beta-adrenoceptor blocking drugs->PROPRANOLOL Propranolol On Formulary HYDROCHLORIDE

PROPRANOLOL HYDROCHLORIDE On Formulary 2.4 Beta-adrenoceptor blocking drugs

2.8 Anticoagulants and protamine->2.8.3 Protamine PROTAMINE SULFATE On Formulary sulfate

2.8 Anticoagulants and protamine->2.8.3 Protamine Protamine Sulfate On Formulary sulfate->PROTAMINE SULFATE

2.5 Hypertension and heart failure->2.5.5 Drugs RAMIPRIL On Formulary affecting the renin-angiotensin system->2.5.5.1 1st Line ACE Inhibitor Angiotensin-converting enzyme inhibitors

2.5 Hypertension and heart failure->2.5.5 Drugs Ramipril On Formulary affecting the renin-angiotensin system->2.5.5.1 1st Line ACE Inhibitor Angiotensin-converting enzyme inhibitors->RAMIPRIL

2.8 Anticoagulants and protamine->2.8.2 Oral Rivaroxaban On Formulary Formulary for NICE indications as recommended by consultant haematologist. anticoagulants

2.8 Anticoagulants and protamine->2.8.2 Oral RIVAROXABAN On Formulary TA256 http://www.nice.org.uk/TA256 Formulary for NICE indications as recommended by consultant haematologist. anticoagulants->Rivaroxaban 2.8 Anticoagulants and protamine->2.8.2 Oral RIVAROXABAN On Formulary TA335 http://www.nice.org.uk/TA335 Formulary for NICE indications as recommended by consultant haematologist. anticoagulants->Rivaroxaban

2.8 Anticoagulants and protamine->2.8.2 Oral RIVAROXABAN On Formulary TA287 http://www.nice.org.uk/TA287 Formulary for NICE indications as recommended by consultant haematologist. anticoagulants->Rivaroxaban

2.8 Anticoagulants and protamine->2.8.2 Oral RIVAROXABAN On Formulary TA261 http://www.nice.org.uk/TA261 Formulary for NICE indications as recommended by consultant haematologist. anticoagulants->Rivaroxaban

2.8 Anticoagulants and protamine->2.8.2 Oral RIVAROXABAN On Formulary TA170 http://www.nice.org.uk/TA170 Formulary for NICE indications as recommended by consultant haematologist. anticoagulants->Rivaroxaban

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Securon SR® On Formulary blockers->VERAPAMIL HYDROCHLORIDE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Securon® On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->VERAPAMIL HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Short-acting tablets and sprays On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE

SIMVASTATIN On Formulary 2.12 Lipid-regulating drugs->Statins 1st Line unless enteral feeding tube administration when Pravastatin preferred.

Simvastatin On Formulary 2.12 Lipid-regulating drugs->Statins->SIMVASTATIN 1st Line Statin unless enteral feeding tube administration when Pravastatin preferred.

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Slozem® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.4 Beta-adrenoceptor blocking drugs->SOTALOL Sotacor® On Formulary HYDROCHLORIDE

2.4 Beta-adrenoceptor blocking drugs->SOTALOL Sotalol On Formulary HYDROCHLORIDE

SOTALOL HYDROCHLORIDE On Formulary 2.4 Beta-adrenoceptor blocking drugs

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and SPIRONOLACTONE On Formulary aldosterone antagonists->Aldosterone antagonists

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Spironolactone On Formulary aldosterone antagonists->Aldosterone antagonists->SPIRONOLACTONE 2.6 Nitrates, calcium-channel blockers, and other Standard formulations On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->DILTIAZEM HYDROCHLORIDE

2.10 Stable angina, acute coronary syndromes, and Streptase® On Formulary 2nd Line for MI. Under review for flap salvage - UNLICENSED indication fibrinolysis->2.10.2 Fibrinolytic drugs->STREPTOKINASE

2nd Line for MI. 2.10 Stable angina, acute coronary syndromes, and STREPTOKINASE On Formulary fibrinolysis->2.10.2 Fibrinolytic drugs Under review for flap salvage - UNLICENSED indication

2.3 Anti-arrhythmic drugs->2.3.2 Drugs for Tambocor® On Formulary arrhythmias->Supraventricular and ventricular arrhythmias->FLECAINIDE ACETATE

2.10 Stable angina, acute coronary syndromes, and 1st Line for MI. Kept on Burns Crash Trolley -NOT Pharmacy TENECTEPLASE On Formulary fibrinolysis->2.10.2 Fibrinolytic drugs Acute Myocardial Guidelines 2009

Tenormin® On Formulary 2.4 Beta-adrenoceptor blocking drugs->ATENOLOL 1st Line Beta-blocker for angina and hypertension

2.2 Diuretics->2.2.1 Thiazides and related Tensaid XL® On Formulary diuretics->INDAPAMIDE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Tensipine MR® On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Tildiem LA® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Tildiem Retard® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Tildiem® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Standard formulations

Mouthwash 5% for prevention of bleeding post-dental extraction in patients on oral TRANEXAMIC ACID On Formulary 2.11 Antifibrinolytic drugs and haemostatics anticoagulants and where bleeding occurs post-op. UNLICENSED.

2.11 Antifibrinolytic drugs and Mouthwash 5% for prevention of bleeding post-dental extraction in patients on oral Tranexamic acid On Formulary haemostatics->TRANEXAMIC ACID anticoagulants and where bleeding occurs post-op. UNLICENSED 2.6 Nitrates, calcium-channel blockers, and other Transdermal preparations On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE

2.6 Nitrates, calcium-channel blockers, and other Transiderm-Nitro® On Formulary antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE->Transdermal preparations

2.5 Hypertension and heart failure->2.5.5 Drugs Tritace® On Formulary affecting the renin-angiotensin system->2.5.5.1 1st Line ACE Inhibitor Angiotensin-converting enzyme inhibitors->RAMIPRIL

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Univer® On Formulary blockers->VERAPAMIL HYDROCHLORIDE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Valni XL® On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->NIFEDIPINE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Verapamil On Formulary antianginal drugs->2.6.2 Calcium-channel blockers->VERAPAMIL HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other VERAPAMIL HYDROCHLORIDE On Formulary antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Verapress MR® On Formulary blockers->VERAPAMIL HYDROCHLORIDE->Modified release

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Vertab® SR 240 On Formulary blockers->VERAPAMIL HYDROCHLORIDE->Modified release

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Viazem XL® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.8 Anticoagulants and protamine->2.8.2 Oral Warfarin On Formulary anticoagulants->Coumarins and phenindione->WARFARIN SODIUM 2.8 Anticoagulants and protamine->2.8.2 Oral WARFARIN SODIUM On Formulary anticoagulants->Coumarins and phenindione

2.8 Anticoagulants and protamine->2.8.2 Oral Xarelto® On Formulary Formulary for NICE indications as recommended by consultant haematologist. anticoagulants->Rivaroxaban->RIVAROXABAN

2.6 Nitrates, calcium-channel blockers, and other Zemon® On Formulary antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE->Modified release

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Zemtard® On Formulary blockers->DILTIAZEM HYDROCHLORIDE->Longer-acting formulations

2.5 Hypertension and heart failure->2.5.5 Drugs Zestril® On Formulary affecting the renin-angiotensin system->2.5.5.1 Angiotensin-converting enzyme inhibitors->LISINOPRIL

Zocor® On Formulary 2.12 Lipid-regulating drugs->Statins->SIMVASTATIN 1st Line Statin unless enteral feeding tube administration when Pravastatin preferred.

2.10 Stable angina, acute coronary syndromes, and Actilyse Cathflo® Restricted Not relevant to QVH for stroke indication. Restricted use in free flap salvage. fibrinolysis->2.10.2 Fibrinolytic drugs->ALTEPLASE

2.10 Stable angina, acute coronary syndromes, and Actilyse® Restricted Not relevant to QVH for stroke indication. Restricted use in free flap salvage. fibrinolysis->2.10.2 Fibrinolytic drugs->ALTEPLASE

2.10 Stable angina, acute coronary syndromes, and ALTEPLASE Restricted TA264 http://www.nice.org.uk/TA264 Not relevant to QVH for stroke indication. Restricted use in free flap salvage. fibrinolysis->2.10.2 Fibrinolytic drugs

2.8 Anticoagulants and protamine->2.8.1 Parenteral Angiox® Restricted Only as per NICE guidance anticoagulants->Hirudins->BIVALIRUDIN

2.8 Anticoagulants and protamine->2.8.2 Oral Formulary for NICE indications. Initiation on advice of Consultant Haematologist, Physician or Apixaban Restricted anticoagulants Cardiologist only. Not relevant to QVH for TA245.

2.8 Anticoagulants and protamine->2.8.2 Oral APIXABAN Restricted TA275 http://www.nice.org.uk/TA275 Initiation by consultant cardiologist/physician only for NICE indications. anticoagulants->Apixaban

2.8 Anticoagulants and protamine->2.8.2 Oral APIXABAN Restricted TA341 http://www.nice.org.uk/TA341 Initiation by consultant cardiologist/physician only for NICE indications. anticoagulants->Apixaban

2.8 Anticoagulants and protamine->2.8.2 Oral APIXABAN Restricted TA245 http://www.nice.org.uk/TA245 Initiation by consultant cardiologist/physician only for NICE indications. anticoagulants->Apixaban

2.8 Anticoagulants and protamine->2.8.1 Parenteral Arixtra® Restricted anticoagulants->Fondaparinux->FONDAPARINUX SODIUM 2.8 Anticoagulants and protamine->2.8.1 Parenteral BIVALIRUDIN Restricted TA230 http://www.nice.org.uk/TA230 Only as per NICE guidance anticoagulants->Hirudins

Brilique® Restricted 2.9 Antiplatelet drugs->TICAGRELOR Formulary for NICE indications only.

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel Cardene SR® Restricted Injection onlyfor intraoperative and perioperative hypertension use only. blockers->NICARDIPINE HYDROCHLORIDE->Modified release

2.6 Nitrates, calcium-channel blockers, and other Cardene® Restricted antianginal drugs->2.6.2 Calcium-channel Injection onlyfor intraoperative and perioperative hypertension use only. blockers->NICARDIPINE HYDROCHLORIDE

2.5 Hypertension and heart failure->2.5.2 Centrally Catapres® Restricted acting antihypertensive drugs->CLONIDINE In ITU for management of agitation and difficult opioid withdrawal -UNLICENSED indication HYDROCHLORIDE

2.8 Anticoagulants and protamine->2.8.1 Parenteral Restricted Item Clexane® Restricted anticoagulants->Low molecular weight For MEDICAL thromboprophylaxis only heparins->ENOXAPARIN SODIUM

2.5 Hypertension and heart failure->2.5.2 Centrally HYDROCHLORIDE Restricted In ITU for management of agitation and difficult opioid withdrawal -UNLICENSED indication acting antihypertensive drugs

2.5 Hypertension and heart failure->2.5.2 Centrally Dixarit® Restricted acting antihypertensive drugs->CLONIDINE In ITU for management of agitation and difficult opioid withdrawal -UNLICENSED indication HYDROCHLORIDE

Efient® Restricted 2.9 Antiplatelet drugs->PRASUGREL Formulary for NICE indications only.

2.8 Anticoagulants and protamine->2.8.2 Oral Eliquis® Restricted Initiation by consultant cardiologist/physician only for NICE indications anticoagulants->Apixaban->APIXABAN

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and EPLERENONE Restricted Only if Spironolactone not tolerated aldosterone antagonists->Aldosterone antagonists

2.8 Anticoagulants and protamine->2.8.1 Parenteral Epoprostenol Restricted Nebulised in ITU for pulmonary - UNLICENSED indication anticoagulants

2.8 Anticoagulants and protamine->2.8.1 Parenteral Restricted Item EPOPROSTENOL Restricted anticoagulants->Epoprostenol Nebulised in ITU for pulmonary vasodilation - UNLICENSED indication

Fibrovein® Restricted 2.13 Local sclerosants->SODIUM TETRADECYL SULFATE Vascular surgery only

2.8 Anticoagulants and protamine->2.8.1 Parenteral Restricted Item Flolan® Restricted anticoagulants->Epoprostenol->EPOPROSTENOL Nebulised in ITU for pulmonary vasodilation - UNLICENSED indication 2.8 Anticoagulants and protamine->2.8.1 Parenteral Fondaparinux Restricted Fondaparinux and NSTEACS anticoagulants

2.8 Anticoagulants and protamine->2.8.1 Parenteral FONDAPARINUX SODIUM Restricted Fondaparinux and NSTEACS anticoagulants->Fondaparinux

2.8 Anticoagulants and protamine->2.8.1 Parenteral Used for heparin soaks NOT as a flush - UNLICENSED indication Heparin flushes Restricted anticoagulants Preparation and Use of Heparin Soaks

2.8 Anticoagulants and protamine->2.8.1 Parenteral Restricted Item Heparin Sodium Restricted anticoagulants->Heparin flushes Used for heparin soaks NOT as a flush - UNLICENSED indication

2.2 Diuretics->2.2.3 Potassium-sparing diuretics and Inspra® Restricted aldosterone antagonists->Aldosterone Only if Spironolactone not tolerated antagonists->EPLERENONE

2.6 Nitrates, calcium-channel blockers, and other ISOSORBIDE MONONITRATE Restricted Only Formulary preparations : 10mg and 20mg tablets and Slow-Release 60mg tablets antianginal drugs->2.6.1 Nitrates

2.6 Nitrates, calcium-channel blockers, and other Restricted TA267 http://www.nice.org.uk/TA267 As per NICE guidance for chronic heart failure. antianginal drugs->2.6.3 Other antianginal drugs

LABETALOL HYDROCHLORIDE Restricted 2.4 Beta-adrenoceptor blocking drugs IV is Formulary, Oral tablets Non-Formulary

2.4 Beta-adrenoceptor blocking drugs->LABETALOL Labetalol Hydrochloride Restricted IV is Formulary, Oral tablets Non-Formulary HYDROCHLORIDE

2.12 Lipid-regulating drugs->Statins->PRAVASTATIN Lipostat® Restricted Recommended statin for administration via enteral feeding tubes. SODIUM

2.6 Nitrates, calcium-channel blockers, and other Modified release Restricted antianginal drugs->2.6.2 Calcium-channel Injection onlyfor intraoperative and perioperative hypertension use only. blockers->NICARDIPINE HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other Only Naftidrofurly oxalate for treatment of intermittent claudication in people with peripheral Naftidrofuryl Restricted antianginal drugs->2.6.4 Peripheral vasodilators and arterial disease as per NICE guidance. related drugs->NAFTIDROFURYL OXALATE

2.6 Nitrates, calcium-channel blockers, and other Only Naftidrofurly oxalate for treatment of intermittent claudication in people with peripheral NAFTIDROFURYL OXALATE Restricted antianginal drugs->2.6.4 Peripheral vasodilators and TA223 http://www.nice.org.uk/TA223 arterial disease as per NICE guidance. related drugs

2.6 Nitrates, calcium-channel blockers, and other Nicardipine Restricted antianginal drugs->2.6.2 Calcium-channel Injection onlyfor intraoperative and perioperative hypertension use only. blockers->NICARDIPINE HYDROCHLORIDE

2.6 Nitrates, calcium-channel blockers, and other NICARDIPINE HYDROCHLORIDE Restricted Injection onlyfor intraoperative and perioperative hypertension use only. antianginal drugs->2.6.2 Calcium-channel blockers 2.6 Nitrates, calcium-channel blockers, and other NIFEDIPINE Restricted Only modified-release preparations recommended antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other PENTOXIFYLLINE Restricted antianginal drugs->2.6.4 Peripheral vasodilators and TA223 http://www.nice.org.uk/TA223 Only for osteonecrosis of the jaw -UNLICENSED indication related drugs

PRASUGREL Restricted 2.9 Antiplatelet drugs TA317 http://www.nice.org.uk/TA317 Formulary for NICE indications only

2.12 Lipid-regulating drugs->Statins->PRAVASTATIN Pravastatin Restricted Recommended statin for administration via enteral feeding tubes. SODIUM

PRAVASTATIN SODIUM Restricted 2.12 Lipid-regulating drugs->Statins Recommended statin for administration via enteral feeding tubes.

2.6 Nitrates, calcium-channel blockers, and other Only Naftidrofurly oxalate for treatment of intermittent claudication in people with peripheral Praxilene® Restricted antianginal drugs->2.6.4 Peripheral vasodilators and arterial disease as per NICE guidance. related drugs->NAFTIDROFURYL OXALATE

2.6 Nitrates, calcium-channel blockers, and other Procoralan® Restricted antianginal drugs->2.6.3 Other antianginal As per NICE guidance for chronic heart failure drugs->IVABRADINE

SODIUM TETRADECYL SULFATE Restricted 2.13 Local sclerosants Vascular surgery only

TICAGRELOR Restricted 2.9 Antiplatelet drugs TA236 http://www.nice.org.uk/TA236 Formulary for NICE indications only.

2.4 Beta-adrenoceptor blocking drugs->LABETALOL Restricted Item Trandate® Restricted HYDROCHLORIDE IV is Formulary, Oral tablets Non-Formulary

2.6 Nitrates, calcium-channel blockers, and other Restricted Item Trental® Restricted antianginal drugs->2.6.4 Peripheral vasodilators and Only for osteonecrosis of the jaw -UNLICENSED indication related drugs->PENTOXIFYLLINE

2.8 Anticoagulants and protamine->2.8.1 Parenteral Restricted Item Veletri® Restricted anticoagulants->Epoprostenol->EPOPROSTENOL Nebulised in ITU for pulmonary vasodilation - UNLICENSED indication

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Candesartan Cilexetil None Angiotensin-II receptor antagonists->CANDESARTAN CILEXETIL

2.11 Antifibrinolytic drugs and DRIED PROTHROMBIN COMPLEX None haemostatics->Blood-related products

2.11 Antifibrinolytic drugs and FACTOR IX FRACTION, DRIED None haemostatics->Blood-related products

2.11 Antifibrinolytic drugs and FACTOR VIIa (RECOMBINANT) None haemostatics->Blood-related products 2.11 Antifibrinolytic drugs and FACTOR VIII FRACTION, DRIED None haemostatics->Blood-related products

FACTOR VIII INHIBITOR BYPASSING 2.11 Antifibrinolytic drugs and None FRACTION haemostatics->Blood-related products

2.11 Antifibrinolytic drugs and FACTOR XIII FRACTION, DRIED None haemostatics->Blood-related products

2.11 Antifibrinolytic drugs and FIBRINOGEN, DRIED None haemostatics->Blood-related products

2.11 Antifibrinolytic drugs and FRESH FROZEN PLASMA None haemostatics->Blood-related products

2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Irbesartan with hydrochlorothiazide None Angiotensin-II receptor antagonists->IRBESARTAN->With diuretic

2.6 Nitrates, calcium-channel blockers, and other ISRADIPINE None antianginal drugs->2.6.2 Calcium-channel blockers

2.6 Nitrates, calcium-channel blockers, and other Isradipine None antianginal drugs->2.6.2 Calcium-channel blockers->ISRADIPINE

2.6 Nitrates, calcium-channel blockers, and other Nicardipine None antianginal drugs->2.6.2 Calcium-channel blockers->NICARDIPINE HYDROCHLORIDE

2.4 Beta-adrenoceptor blocking drugs->PROPRANOLOL Propranolol m/r preparations None HYDROCHLORIDE->Modified release

2.11 Antifibrinolytic drugs and PROTEIN C CONCENTRATE None haemostatics->Blood-related products

2.4 Beta-adrenoceptor blocking drugs->TIMOLOL Timolol None MALEATE